Pharmaceutical compound
 | |
| Identifiers | |
|---|---|
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C14H18FNO |
| Molar mass | 235.302 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
2F-NENDCK (CanKet, 2-Fluoro-N-Ethylnordeschloroketamine, 2'-Fluoro-2-Oxo-Phenylcyclohexylethylamine, 2'-Fluoro-2-Oxo-PCE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects presumably similar to those of ketamine. Its general effects, dissociative or otherwise, may deviate from other arylcyclohexylamines.
It was initially identified in Canberra, Australia in mid-August 2022 by the government-funded drug-testing service CanTEST. It has since been dubbed "CanKet" due to it originally being found in Canberra and being a structural analogue of ketamine. It has subsequently been discovered in Taiwan, China and New Zealand.
Uses and Effects
Uses
Due to the lack of research pertaining to it, there are no known legitimate uses for CanKet. Its long-term effects on the human body are unknown, and therefore, it is generally advised for individuals to refrain from consuming CanKet, as is the case for most other designer drugs.
Effects
While not much is known about the drug's effects, anecdotal reports offer some insight into them. According to a VICE News interview with one anonymous recreational user,
"it’s worse but only slightly… The ‘happy’ feeling was lacking a little bit. I find I snort K and a smile forms on my face when it starts kicking in. This was lacking that—I’d just come up and kinda stay in a mundane headspace while feeling wonky."
On online forums, users report conflicting information about its effects, with some users reporting a stimulating effect. Most agree that the duration of its effects is four to six hours, much longer than ketamine's duration, which typically is approximately one hour when insufflated.
While such anecdotal reports may shed some light on CanKet's effects, it is important to note that these are highly subjective, and individual differences may lead to different users experiencing different effects. Professor Malcom MacLeod, an associate professor at the Australian National University's research school of chemistry, while speaking on the topic of CanKet, stated, "We don't know much about its effects," observing that users' accounts of the effects vary and are "often quite subjective and a bit hard to unravel exactly what’s going on."
Chemistry
Structure
Chemically, CanKet is a fluorinated arylcyclohexylamine and a ketamine derivative. It is quite similar to ketamine structurally but differs in a few ways:
- Fluorination: in CanKet, one hydrogen atom on the aryl group is replaced with a fluorine atom.
- N-ethyl group: the N-methyl group normally found in ketamine is replaced with an N-ethyl group in CanKet.
- Deschlorination: CanKet lacks a chlorine atom, which is present on the phenyl ring in ketamine.
See also
References
- "ANU scientists make Australian-first detection of new drug | Australian National University". www.anu.edu.au. 2022-10-18. Retrieved 2024-11-16.
- Burke M (3 November 2022). "Alarm sounded after chemists discover new analogue of ketamine in Australia". Chemistry World.
- Caldicott D, McLeod M (2022-10-20). "An entirely new illicit drug has been discovered by Australian chemists. Here's how they did it". The Conversation. Retrieved 2024-06-06.
- Yen YT, Tsai YS, Su WL, Huang DY, Wu HH, Tseng SH, et al. (December 2022). "New ketamine analogue: 2-fluorodeschloro-N-ethyl-ketamine and its suggested metabolites". Forensic Science International. 341: 111501. doi:10.1016/j.forsciint.2022.111501. PMID 36274344. S2CID 252975335.
- Wang KD, Yuan XL, Liu C, Cao FQ, Zhang YR, Liu WB, et al. (January 2023). "Identification of three novel new psychoactive substances 4F-AB-BUTINACA, AB-PHETINACA, and 2F-NENDCK". Drug Testing and Analysis. 15 (1): 115–122. doi:10.1002/dta.3359. PMID 35986510. S2CID 251693947.
- "Ketamine analogue sold as ketamine in the Wellington region". High Alert. Retrieved 2024-06-07.
- ^ "Scientists Discover 'Disconcerting' New Imitation Ketamine on the Market". VICE. 2022-10-18. Retrieved 2024-11-16.
- ^ "Safer Using - 2F-NENDCK (CanKet)". CAHMA. Retrieved 2024-11-16.
- Sinner B, Graf BM (2008). "Ketamine". In Schüttler J, Schwilden H (eds.). Modern Anesthetics. Berlin, Heidelberg: Springer. pp. 313–333. doi:10.1007/978-3-540-74806-9_15. ISBN 978-3-540-74806-9. Retrieved 2024-11-16.
 | This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |